NIVFNasdaqServices-Misc Health & Allied Services, NECAlso trades as NIVFW
NewGenIvf Group Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.28+0.00 (+1.47%)
Close on Oct 19, 2026
Market cap
–
P/E (TTM)
0.1
Dividend yield
–
NewGenIvf statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Services-Misc Health & Allied Services, NEC companies for comparison
Valuation
Measure
NewGenIvf
Industry median
Market Cap
$68.23K
$1.11B
Enterprise Value
-$1.34M
$1.41B
PE Ratio
0.09
22.72
PS Ratio
0.01
1.60
PB Ratio
0.00
3.03
P/TBV Ratio
0.01
4.99
Enterprise value
Measure
NewGenIvf
Industry median
EV / Sales
-0.28
1.69
Income (trailing twelve months)
Measure
NewGenIvf
Industry median
Revenue
$4.73M
$561.90M
Gross Profit
$955.85K
$173.32M
Operating Income
-$10.73M
-$1.81M
Pretax Income
$9.73M
-$572.42K
Net Income
$9.88M
-$1.16M
EBITDA
-$10.54M
-$20.72K
EPS (Diluted)
$3.04
-$0.02
Margins
Measure
NewGenIvf
Industry median
Gross Margin
20.2%
33.1%
Operating Margin
-226.9%
-4.45%
Pretax Margin
205.8%
1.54%
Profit Margin
209.0%
-2.91%
EBITDA Margin
-223.0%
2.41%
FCF Margin
-234.0%
3.13%
Returns
Measure
NewGenIvf
Industry median
Return on Equity (ROE)
77.2%
1.84%
Return on Assets (ROA)
54.4%
-3.06%
Return on Invested Capital (ROIC)
-69.6%
2.11%
Return on Capital Employed (ROCE)
-35.3%
-0.57%
Growth
Measure
NewGenIvf
Industry median
Revenue Growth (YoY)
-13.0%
6.92%
Revenue Growth (3Y CAGR)
-7.36%
10.9%
EPS Growth (3Y CAGR)
-13.6%
19.8%
Balance sheet
Measure
NewGenIvf
Industry median
Cash & Short-Term Investments
$758.62K
$48.71M
Net Cash (Debt)
$758.62K
$205.49K
Net Cash Per Share
$3.15
$0.01
Equity (Book Value)
$26.63M
$235.16M
Book Value Per Share
$110.50
$3.48
Tangible Book Value
$5.22M
$703.69K
Working Capital
$5.02M
$30.48M
Financial position
Measure
NewGenIvf
Industry median
Current Ratio
3.12
1.40
Quick Ratio
0.39
1.02
Interest Coverage
-17.40
-0.63
Cash flow (trailing twelve months)
Measure
NewGenIvf
Industry median
Operating Cash Flow
-$10.93M
$3.10M
Capital Expenditures
-$135.03K
-$18.62M
Free Cash Flow
-$11.06M
$23.73M
FCF Per Share
-$45.90
$0.37
Efficiency
Measure
NewGenIvf
Industry median
Asset Turnover
0.26
0.87
Inventory Turnover
18.12
11.67
Revenue Per Employee
$54.33K
$228.48K
Profits Per Employee
$113.56K
-$5.75K
Employee Count
87
910
Dividends and yields
Measure
NewGenIvf
Industry median
Earnings Yield
14480.1%
-0.59%
FCF Yield
-16212.0%
1.74%
Buyback Yield
-18497.6%
0.32%
Shareholder Yield
-18497.6%
0.65%
Shares
Measure
NewGenIvf
Industry median
Shares Outstanding
241,002
58,282,400
Shares Change (YoY)
2731010.0%
2.68%
Scores
Measure
NewGenIvf
Industry median
Graham Number
$86.94
$19.59
Graham Upside
30609.7%
-47.5%
Altman Z-Score
-0.37
2.05
Piotroski F-Score
5
5
Beneish M-Score
10.51
-2.71
Calculated by StockData from NewGenIvf's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.